miR-142-3p Controls the Specification of Definitive Hemangioblasts during Ontogeny

被引:61
作者
Nimmo, Rachael [1 ]
Ciau-Uitz, Aldo [2 ]
Ruiz-Herguido, Cristina [3 ]
Soneji, Shamit [1 ]
Bigas, Anna [3 ]
Patient, Roger [2 ]
Enver, Tariq [1 ]
机构
[1] UCL Canc Inst, Stem Cell Lab, London WC1E 6BT, England
[2] Univ Oxford, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford OX3 9DS, England
[3] PRBB, Inst Hosp Mar Invest Med IMIM, Canc Res Program, Barcelona 08003, Spain
关键词
STEM-CELL DEVELOPMENT; TGF-BETA INHIBITION; MICRORNA BIOGENESIS; AORTIC ENDOTHELIUM; EMBRYONIC BLOOD; UP-REGULATION; MOUSE; HEMATOPOIESIS; ADULT; LINEAGE;
D O I
10.1016/j.devcel.2013.06.023
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hematopoietic stem cells (HSCs) emerge during embryogenesis from hemogenic endothelium, but it remains unclear how the HSC lineage is initially established from mesoderm during ontogeny. In Xenopus, the definitive hemangioblast precursors of the HSC lineage have been identified in dorsal lateral plate (DLP) mesoderm, and a transcriptional gene regulatory network (GRN) controlling hemangioblast programming has been elucidated. Herein, we identify an essential role for microRNAs (miRNAs) in establishing the mesodermal lineage leading to both HSC emergence and vasculogenesis and determine that a single miRNA, miR-142-3p, is primarily responsible for initiation of definitive hemangioblast specification. miR-142-3p forms a double-negative gate unlocking entry into the hemangioblast program, in part by inhibiting TGF beta signaling. Our results table miR-142-3p as a master regulator of HSC lineage specification, sitting at the apex of the hierarchy programming the adult hemangioblast, thus illustrating that miRNAs can act as instructive determinants of cell fate during development.
引用
收藏
页码:237 / 249
页数:13
相关论文
共 62 条
[1]   The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1 [J].
Agrawal, Raman ;
Tran, Uyen ;
Wessely, Oliver .
DEVELOPMENT, 2009, 136 (23) :3927-3936
[2]   Stop the dicing in hematopoiesis What have we learned? [J].
Alemdehy, Mir Farshid ;
Erkeland, Stefan J. .
CELL CYCLE, 2012, 11 (15) :2799-2807
[3]   Highly Efficient miRNA-Mediated Reprogramming of Mouse and Human Somatic Cells to Pluripotency [J].
Anokye-Danso, Frederick ;
Trivedi, Chinmay M. ;
Juhr, Denise ;
Gupta, Mudit ;
Cui, Zheng ;
Tian, Ying ;
Zhang, Yuzhen ;
Yang, Wenli ;
Gruber, Peter J. ;
Epstein, Jonathan A. ;
Morrisey, Edward E. .
CELL STEM CELL, 2011, 8 (04) :376-388
[4]  
[Anonymous], 1994, Normal table of xenopus laevis (Daudin): A systematical and chronological survey of the development from the fertilized egg till the end of metamorphosis
[5]   MicroRNAs: new regulators of immune cell development and function [J].
Baltimore, David ;
Boldin, Mark P. ;
O'Connell, Ryan M. ;
Rao, Dinesh S. ;
Taganov, Konstantin D. .
NATURE IMMUNOLOGY, 2008, 9 (08) :839-845
[6]   Dicer is essential for mouse development [J].
Bernstein, E ;
Kim, SY ;
Carmell, MA ;
Murchison, EP ;
Alcorn, H ;
Li, MZ ;
Mills, AA ;
Elledge, SJ ;
Anderson, KV ;
Hannon, GJ .
NATURE GENETICS, 2003, 35 (03) :215-217
[7]   Haematopoietic stem cells derive directly from aortic endothelium during development [J].
Bertrand, Julien Y. ;
Chi, Neil C. ;
Santoso, Buyung ;
Teng, Shutian ;
Stainier, Didier Y. R. ;
Traver, David .
NATURE, 2010, 464 (7285) :108-U120
[8]   Combined Characterization of microRNa and mRNa Profiles Delineates Early Differentiation Pathways of CD133+ and CD34+ Hematopoietic Stem and Progenitor Cells [J].
Bissels, Ute ;
Wild, Stefan ;
Tomiuk, Stefan ;
Hafner, Markus ;
Scheel, Hartmut ;
Mihailovic, Aleksandra ;
Choi, Yeong-Hoon ;
Tuschl, Thomas ;
Bosio, Andreas .
STEM CELLS, 2011, 29 (05) :847-857
[9]   In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium [J].
Boisset, Jean-Charles ;
van Cappellen, Wiggert ;
Andrieu-Soler, Charlotte ;
Galjart, Niels ;
Dzierzak, Elaine ;
Robin, Catherine .
NATURE, 2010, 464 (7285) :116-U131
[10]   Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice [J].
Bueno, Lorea ;
de Alwis, Dinesh P. ;
Pitou, Celine ;
Yingling, Jonathan ;
Lahn, Michael ;
Glatt, Sophie ;
Troconiz, Inaki F. .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (01) :142-150